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ABSTRACT 
The purpose of this study was to evaluate the stability of mini-screw implants 
(MSIs) placed with and without OsteoCrete bone cement.  Using a randomized split-
mouth design in 6 skeletally mature male beagle dogs, 23 MSIs were placed in the 
maxillary alveolar bone with OsteoCrete and 23 MSIs were placed without OsteoCrete.  
MSI stability was evaluated each week with an Osstell IDx.  Histology was used to 
analyze the surrounding bone of the control and OsteoCrete MSIs.  Micro-CT was used 
to analyze the bone volume fraction and the bone mineral density around the MSIs.  The 
success rate of the control MSIs (87%) was higher than the success rate of the 
experimental MSIs (78.3%), but the difference was not statistically significant 
(p=0.437).  All of the MSI failures occurred between weeks 1 and 4.  MSIs inserted with 
OsteoCrete exhibited an initial decrease in primary stability, but they did not show the 
increases in secondary stability seen in the control MSIs.  Bone mineralization occurred 
around the outer boundaries of OsteoCrete but not within the OsteoCrete.  The 
OsteoCrete was not being actively remodeled by osteoclasts.  There was no difference in 
bone volume fraction or bone mineral density in the layer of bone around the OsteoCrete 
and control MSIs.  In conclusion, OsteoCrete does not make MSIs more stable; it makes 
them less stable.  
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CHAPTER I 
INTRODUCTION AND LITERATURE REVIEW 
OVERVIEW 
Many orthodontic treatments require skeletal anchorage in order to achieve the 
best results possible.  The most commonly used skeletal anchors in orthodontics are 
mini-screw implants (MSIs).  MSIs are important in orthodontic treatment of 
malocclusions requiring absolute anchorage such as bimaxillary protrusion treatments to 
obtain maximum retraction, intrusion protocols for open bite treatment, maxillary 
dentoalveolar distalization in Class II patients, and other orthodontic treatments to 
prevent unwanted reciprocal forces.  MSIs can be placed by the orthodontist; many 
times, at no additional cost to the patient.  Many orthodontists do not consider using 
MSIs when treating patients due to past experiences with MSI mobility and failures.  
When MSIs fail it can cause orthodontists to lose confidence in the use of MSIs and it 
can cause patients to lose confidence in the orthodontist.1  This can lead orthodontists to 
provide suboptimal treatment without skeletal anchorage.  A meta-analysis and two 
systematic reviews have reported MSI success rates to be 80%-86.5% in humans.2-4  The 
success rates of MSIs are significantly lower than the success rates of titanium 
endosseous dental implants, which have been reported to be 90% to 100%.5,6  The field 
of orthodontics needs a more predictable method for MSI placement, that increases the 
stability and success of MSIs.   
MSIs typically exhibit significant decreases in stability during the first 3 weeks, 
up to the primary to secondary stability transition.7   Primary stability, which is 
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mechanical and due to the cortical and trabecular bone contact with the MSI, decreases 
due to the osteoclastic removal of bone damaged due to the compression and 
microfractures during MSI placement. 8-10  Increases in secondary stability are due to 
cortical and trabecular bone repair and intimate contact with the MSI (osseointegration 
or bone-to-implant contact).  If the primary stability could be enhanced, it would 
minimize the initial decrease in stability and increase overall stability, leading to more 
successful MSIs. 
Primary stability could be enhanced if there were a bone cement that diffuses into 
the trabecular bone and bonds to the MSI.  Assuming that the cement resorbs over time, 
this would enhance the initial mechanical stability until full secondary stability could be 
achieved.  OsteoCrete is a magnesium based bone cement that has been shown to 
increase the stability of stainless steel screws in a horse study.11  OsteoCrete has been 
shown to be both biocompatible and osseoconductive.12,13  A dog study using immediate 
dental implants showed that there was new bone formation over the top of the 
OsteoCrete and minimal inflammatory reaction.13  There have not been any studies that 
have investigated at MSI placement with adjunctive bone cements.   
 The purpose of the present study was to evaluate the stability of MSIs placed 
with and without OsteoCrete bone cement.  Another purpose was to evaluate the tissue 
response to the OsteoCrete.   
The hypothesis of the present study was that there would be a significantly higher 
stability for SLA MSIs placed with OsteoCrete compared to SLA MSIs only. 
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LITERATURE REVIEW 
History of the Use of Implants in Dentistry 
Gainsforth and Higley first reported the use of implants for orthodontic 
anchorage in 1945.14  They drilled 2.4 mm pilot holes and placed 3.4 mm x 13 mm 
vitallium screws in the ramus of six mongrel dogs, with the goal of using an elastic from 
the screws to retract the maxillary canines.  All of the vitallium screws failed within 16 
days to 29 days after placement.  They attributed loosening and failure of the screws to 
possible cellular reaction to the vitallium screws or the exposure of the screws to the oral 
cavity and subsequent microorganisms.  The first clinical report using an implant for 
orthodontic anchorage was by Creekmore and Eklund in 1983.15  They placed a 13 mm 
vitallium screw below the anterior nasal spine and used it for anchorage to intrude the 
maxillary incisors to correct the patient’s deepbite and excessive gingival display.   
Since then, numerous clinical studies using endosseous dental implants for 
orthodontic anchorage have been published.16-18  In 1964, Branemark et al found that it 
was possible to secure a firm anchorage of titanium appliances in the bone. 19  The 
appliance was very stable with no undesired side effects on the hard or soft tissues.  
They also reported osseointegration of the titanium implants, defined as “a direct – on 
the light microscopic level – contact between living bone and implant”, which is the 
most important factor for the success or failure of implants.20  The use of endosseous 
dental implants in the palate and retromolar area allowed for absolute orthodontic 
anchorage.  However, there are numerous disadvantages associated with the use of 
endosseous dental implants for orthodontic anchorage.  First, an endosseous dental 
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implant requires a surgical procedure for placement and removal, which results in 
significant morbidity and cost.  Second, after the placement of these implants there is a 
two to six month healing period for osseointegration prior to loading the implants.  
Third, the size of the implant was sometimes larger than the space available for 
placement. 
Kanomi was aware of these limitations and sought out an alternative to the use of 
endosseous dental implants.21  He introduced the first mini implant for orthodontic use.  
The mini screws were 1.2 mm in diameter and 6 mm long, which opened up many more 
placement sites.  The mini implants that Kanomi used were originally designed to be 
used for fixation with bone plates in craniofacial surgeries.  Kanomi stated that “a mini-
implant for orthodontic anchorage should be small enough to place in any area of the 
alveolar bone, even in apical bone.  The surgical procedure should be easy enough for an 
orthodontist or general dentist to perform and minor enough for rapid healing.  The 
implant should be easily removable after orthodontic traction.”  The question of how 
long and how wide a mini screw implant needs to be has been well studied and 
manufactures have produced many different sizes of titanium MSIs.  The diameters of 
most MSI systems range from 1 to 2 mm and the lengths range from 3 to 14 mm.   
MSIs are being used by more orthodontists each year.  A survey of AAO 
members in 2008 found that 54.5% of the 564 respondents were placing their own 
MSIs.1  A survey in 2011 found that the majority of the orthodontists, 69.2% of private 
practitioners and 82.9% of residency programs placed their own MSIs.22  This study also 
found that practitioners reported success rates of 83.9% for self-drilling MSIs, while the 
5 
 
mean for the residency programs was 80.1%.  There have been three studies, two 
systematic reviews and one meta-analysis, reporting MSI failure rate ranged from 
13.5%-20%.2-4  Failures can result in the patient and parent losing confidence in the 
orthodontist, extended treatment time, and loss of anchorage. Research continues to be 
done looking into ways of increasing the stability of MSIs.   
 
Failure and Success 
While MSIs continue to be used more and more in academic and private 
orthodontic practices, their failure rates remain less than desired.  In most cases, it is 
necessary for the MSI to remain stable for at least 6 months and up to two years.  The 
failure rates of MSIs have been reported to vary greatly.  However, two systematic 
reviews and one meta-analysis found the MSIs fail at rates of 13.5% to 20%.2-4  The 
success rates of MSIs are significantly lower than the success rates of titanium 
endosseous implants, which have been reported to have success rates of 90% to 100%.5,6  
In 2015, Moraschini et al performed a systematic review that included 7711 endosseous 
implants, with a mean follow up time of 13.4 years, and found the success rate was 
94.6%.5  In 2012, Papageorgiou et al performed a meta-analysis of 52 studies, which 
included 4987 miniscrew implants inserted in 2281 patients.2  The overall failure rate 
was 13.5% with a 95% confidence interval of 11.5-15.8%.  In 2009, Reynders et al 
performed a systematic review of 19 articles, with each article reporting on between 12 
and 480 miniscrew implants.3  Success rates were between 0% and 100%, but most 
articles reported greater than 80%, or failure rates of less than 20%, if displaced and 
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mobile implants were not considered failures.  In 2009, Schatzle et al performed a 
systematic review of 27 articles, with a total of 2374 miniscrews inserted in 1196 
patients.  There were 363 MSIs that failed, representing a15.3% failure rate. 
The MSI success rate is good enough to advocate the use of MSIs when they are 
needed for maximum anchorage or poor compliance.  However, the orthodontist is going 
to have to replace an MSI in 13.5% to 20% of the cases due to failure which could result 
in extended treatment time, patient loss of confidence, increased patient discomfort, and 
increased cost to the orthodontist.  If the stability and success rate of MSIs could be 
improved it would help decrease all of the problems listed above.  In a 2008 survey of 
AAO members on miniscrew usage performed by Buschang et al, they found that 
orthodontists with failure rates of greater than 25% were much less satisfied with MSIs 
when compared to the orthodontists with less than 10% failure rates, who were almost 
all satisfied with MSIs.1 
There are a number of hypotheses that have been proposed to explain MSI 
failures:  cervically placed MSI’s may have deflection of the alveolar bone, MSI’s 
placed near the periodontal ligament of teeth, low bone density, thin cortical plates, 
excessive pressure during placement causing trabecular bone microfractures, and 
excessive gingival thickness causing a decreased amount of MSI within the bone.23  The 
interdental alveolar bone is flexible and deformable.  The more cervical the interdental 
alveolar bone the more delicate the bone is.  This can result in a decreased primary 
stability.  The bases of the maxillary and mandibular alveolar processes are not as 
flexible and deformable, thus resulting in a better placement site for successful mini 
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screws.  With these two considerations; the more cervical an MSI is placed the increased 
risk of failure, compared to the more apical an MSI is placed the better the prognosis.   
 
Bone Healing 
 The events that occur during bone healing around implants appear to be the same 
as the events that occur during fracture healing.24  There are four major stages of bone 
healing: hematoma, clot resolution, osteogenic cell migration, and de novo bone 
formation.  The first thing that occurs in implant placement and fracture healing is the 
formation of a hematoma (blood clot).  The hematoma is made up predominately of red 
blood cells and platelets.  While the red blood cells serve little purpose in bone healing, 
the platelets provide a number of growth factors and vasoactive factors through platelet 
degranulation.  These factors help to recruit neutrophils, macrophages, and mesenchymal 
cells, including fibroblasts and osteoblasts, from the circulation and adjacent bone 
marrow.  Platelet degranulation also helps to activate the cascade to form the fibrin 
within the blood clot.  The osteogenic cells migrate to the implant surface through the 
fibrin within the hematoma which is aided by the cytokine and growth factor release 
from the platelets and leukocytes.  These osteogenic cells are then available to 
synthesize de novo bone on the actual implant surface (contact osteogenesis).  There are 
also osteogenic cells which synthesize de novo bone on the existing bone surrounding 
the implant (distance osteogenesis).  This is the process that leads to true bone-to-
implant contact (BIC) around the implants.  BIC is what is responsible for the sustained 
stability (secondary stability) and long term success of the implant.9 
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 In 2003, Berglundh et al performed a study to evaluate the process of new 
alveolar bone formation adjacent to dental endosseous implants in dogs.9  They used 120 
endosseous implants in 20 labrador dogs to evaluate bone healing between 2 hours and 
12 weeks.  After 2 hours, the wound chamber was filled with coagulum, including large 
numbers of erythrocytes and inflammatory cells.  After four days, the wound chamber 
tissue was rich in vascular structures, connective tissue cells trapped in organic stroma, 
and some inflammatory cells were present.  After one week, the first signs of bone 
formation were observed, with primary spongiosa including trabeculae and woven bone 
present around the vascular units with osteoblasts and osteocytes.  After two weeks, 
there was mineralized bone contacting the entire SLA surface.  The woven bone 
contained osteocytes and osteoblasts were lining the trabeculae.  After six weeks, there 
was a mix of woven bone and parallel-ﬁbered lamellar bone.  After 8 and 12 weeks, 
there was mature bone with bone marrow in contact with the SLA surface of the implant.  
It has been estimated that wound healing, along with bone remodeling, occur about 1.5 
times faster in dogs than in humans; so this would put the transition of primary and 
secondary stability of implant healing in humans at approximately three weeks post-
operative. 
 
Primary and Secondary Stability 
MSIs stability can be depicted by two curves: the primary stability curve, which 
pertains to the retention of the MSI produced by the initial contact between the implant 
and bone, and the secondary stability curve, associated with the remodeling and 
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deposition of new bone around the implant over time (osseointegration/bone implant 
contact).9,25,26  Primary stability occurs right after the implant is placed.  On the other 
hand, secondary stability is more of a biological process that is caused by the 
osseointegration of the MSI with deposition/remodeling of bone around the implant.8,9 
MSIs can fail if there is not intimate contact between the cortical bone (i.e. due to 
the lack of primary stability) and the implant.27  Failure can occur if the implant moves 
or is not tightly screwed into the bone.8  One common mistake during implant placement 
that can lead to a decrease in primary stability is wobbling, or various lateral forces, 
during implant placement with a manual driver.  MSIs can also fail if the biological 
process of osseointegration (secondary stability) does not occur.  Primary stability has 
been reported to be critical for the success of implants and the development of secondary 
stability.28  Ivanoff et al found that the total initial instability of the implants results in 
less bone formation around the implants in rabbits.29  The lower primary stability 
resulted in less bone to implant contact.  Javed et al performed a study evaluating the 
role of primary stability leading to successful osseointegration of titanium dental 
implants.30  They found that the main factors influencing primary stability include bone 
quantity, bone quality, surgical technique, and various implant designs.  The factors that 
influence secondary stability include primary stability, normal bone remodeling, and 
various implant surface conditions.  The implant must mechanically adapt, after initial 
placement, to the host bone until secondary stability can be achieved.  
Using four male adult macaca fascicularis monkeys, Melsen et al evaluated 
implants used for orthodontic anchorage being immediate loaded.31  They performed 
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histomorphometric analyses on the MSI samples and found that the osseointegration 
ranged from 10% to 58% depending on the amount of time after MSI insertion.  
Osseointegration was independent of the type of bone and applied force level.  
Osseointegration increased each month up to the final sample (six months). 
Ure et al evaluated the stability of 1.6 mm diameter and 9 mm long MSIs using 
the Osstell Mentor in a split mouth design.  They drilled 1.1 mm diameter and 3 mm 
deep pilot holes prior to MSI insertion.  They found that the stability decreased during 
the first three weeks and began to increase during the three to five week period.  They 
graphically demonstrated the transition from primary stability, week one through three, 
to secondary stability, all weeks after three.  They also found that the stability values 
between the pilot hole side and no pilot hole side were comparable.7   
 
Methods of Primary and Secondary Stability Measurement 
 There are a number of methods to assess stability of implants.  The two main 
types of evaluations used are biological and biomechanical.  The biological evaluations 
include: histomorphometric analysis, micro-computed tomography, and radiographic 
analysis.  The biomechanical evaluations include: resonance frequency analysis, 
insertion torque, removal torque, pullout test, percussion test, cutting torque resistance 
analysis, and impact hammer method.32-34   
Histomorphometric Analysis 
 Histomorphometric analysis has been utilized by numerous studies to evaluate 
the amount of BIC with orthodontic MSIs and dental implants.35-37  The 
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histomorphometric analysis can be performed using decalcified sections without the MSI 
in the specimen and stained with H&E or embedding the specimens in methyl 
methacrylate with the MSI present.  The two available methods give a two dimensional 
estimate of BIC and allows for the microscopic study of the cells and tissue.   
For example, Woods et al measured BIC of MSIs to determine the effect of 
force, timing, and location.36  They utilized histomorphometric analyses using a light 
microscope and Metamorph software.  Their samples were dehydrated using a series of 
ethanol baths, embedded with methyl methacrylate, and horizontally sectioned with a 
Buehler Isomet Saw.  The 125 micron sections were mounted on glass slides and 
polished to 70 microns using silicon carbide paper.  The sections were stained using 
Stevenel’s blue and then Van Geison counterstain.  The sections were imaged at a 2.5x 
magnification.  The percent BIC of each MSI was measured at three different levels: 
coronal (cortical), middle trabecular, and apical trabecular.  They concluded that only 
limited amounts of osseointegration could result in adequate implant stability as 
determined by histomorphometric analyses.   
 Freire et al performed histomoporphometric analyses on their MSI specimens 
using traditional H&E.35  The specimens were decalcified by soaking them in EDTA and 
formic acid for 14 days and 48 hours, respectively.  The MSIs were removed from the 
decalcified specimens.  They were then mounted in paraffin and were sectioned at 5 
microns down the mesio-distal long axis.  The 5 micron sections were stained with H&E 
for light microscopy evaluation.  The specimens were analyzed at 40x magnification.  
12 
 
The BIC in the histomorphometric measurements was determined by measuring the 
perimeter of bone and implant interaction. 
Micro-computed Tomography 
 Micro-computed tomography (Micro-CT) is an invasive, non-destructive method 
that can be used to assess bone around implants.  Micro-CT is invasive because the 
sample of interest must be removed from the subject in order to be scanned.  It is non-
destructive because the sample can be used at a later time for histology or various other 
measurements.  Micro-CT evaluation produces high resolution, three dimensional, 
images of bone samples that allow quantitative analysis of the cortical and trabecular 
bone around an implant.38  Micro-CT allows for 3D quantitative analysis of the bone 
surrounding the entire implant, whereas histomorphometric analysis only allows for 2D 
quantitative analysis of limited ground sections of each specimen.39  Numerous studies 
have compared the morphometric results of trabecular bone obtained from micro-CT 
with the histomorphometric results of the same specimens.39-42   
Butz et al found that the correlation between histology and micro-CT was 
significant for cortical (r = 0.65, P < .05) and cancellous bone (r = 0.92, P < .05) at 24 to 
240 microns from the implant surface, but there was no significant correlation found for 
the 0 to 24 micron region from the implant surface.40  Their specimens were scanned at 8 
micrometers.  They stated that there is a need for further research to address the inherent 
metallic halation artifact, which can confound the bone assessment near implants when 
using micro-CT.   
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Rebaudi et al reported that measurements of bone-to-implant contact obtained by 
micro-CT were similar to those obtained with standard undecalcified histology.39  They 
also stated that there was a 45 micrometer thick area surrounding the surface of the 
implant which could have obscured the bone measurements.  They scanned the 
specimens at 20 micrometers so if a higher resolution scan is performed the metal 
halation artifact could be reduced.   
Van Oosterwyck et al qualitatively compared micro-CT slices and histological 
sections from the same specimens.41 They found that the overall trabecular structure is 
very similar according to both techniques. They also found that the titanium implant 
does not seem to produce significant artifacts even very close to the interface. However, 
they did note that there were areas around the threads of the implants on the micro-CT 
images that could be metal halation artifacts.  The specimens were scanned at a 
resolution of 60 micrometers. 
In 2011, Ikeda et al assessed bone volume fraction (bone volume/total volume) in 
the peri-implant area of SLA and machine surfaced MSIs using micro-CT at a resolution 
of 6 micrometers.32  They analyzed the regions from 6 to 24 micrometers and 24 to 42 
micrometers and were able to accurately visualize and quantify the bone volume fraction 
of the cortical and trabecular areas.  The 0 to 6 micrometer area was not evaluated 
because of the potential metallic halation effects.  Massey et al also used this technique 
for assessing the bone volume fraction around MSIs that had been loaded with either 200 
or 600 g of force.43  They evaluated three layers of bone extending 6 to 24 micrometers, 
24 to 42 micrometers, and 42 to 60 micrometers from the surface of the MSI. 
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Resonance Frequency Analysis (Osstell Mentor) 
Resonance frequency analysis (RFA) is a non-invasive method that quantitatively 
determines implant stability.28,44-46  Current RFA systems are considered third generation 
and are wireless, battery powered, and portable.47  The measurements are given as 
implant stability quotients (ISQ) which are valid for the transducer that is calibrated for 
each specific type of implant by the manufacturer.  This allows the comparison of ISQ 
values with different types of implants.   
The Osstell Mentor system is a third generation RFA system, consisting of a 
small metal peg transducer (smartpeg) that screws into the head of the MSI.  The 
smartpeg contains a magnet at the top of the peg that is excited by the handheld wand 
that emits magnetic pulses.  This results in micro-vibrations of the smartpeg that the 
computer quantifies as the implant stability quotient (ISQ).  The ISQ can range from 1 
(lowest stability) to 100 (highest stability).  Higher ISQ values indicate increased 
stability, whereas lower ISQ values indicate decreased stability.48  The ISQ value 
depends on three factors: the transducer design, the stiffness of the implant and its BIC, 
and the implant length above of the marginal bone level.47,49     
ISQ quantifies the MSI stability by providing an indirect measurement of 
osseointegration.  Ersanli et al used RFA to evaluate the stability of dental implants 
during the osseointegration period.  They found that the ISQ values decreased during the 
first three weeks after placement and recovered back to near initial ISQ values at the 
loading appointment (3 or 6 months).50   
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Huang et al performed a finite element model study using RFA to assess the 
differences of implant stability in different bone qualities.46  They found that the RFA 
values were almost four times higher in type I bone than in type IV bone.  They also 
found that as density decreases in type III bone RFA values decrease in a linear fashion. 
 
OsteoCrete 
 If primary stability could be enhanced, then the primary stability curve would not 
decrease or decrease more slowly.  This would enhance overall stability two ways.  First, 
it would ensure that MSIs remain more stable during the first 3 weeks, allowing healing 
and secondary stability to proceed without a dip in the stability curve.  Second, it would 
enhance overall stability because secondary stability is related to primary stability (see 
review above).  Primary stability could be enhanced by bone cement that maintains the 
stability of MSIs.  
OsteoCrete is a magnesium phosphate biomaterial that is osteoconductive, 
biohesive, and has high strength characteristics.11,12,51,52  OsteoCrete currently has FDA 
510(k) approval as a bone void filler for pelvis and long bone applications.  The 
formulation of OsteoCrete allows it to be both injectable and moldable.  OsteoCrete has 
two components that are mixed together to form magnesium potassium phosphate.  One 
component is the granular, powder portion containing monopotassium phosphate (54%), 
magnesium oxide (33%), small amounts of tricalcium phosphate (9%), and dextrose 
(4%); the other component is a modified saline solution.11  The components are mixed in 
a plastic mixing bowl with a mixing spatula.  The sterile saline solution is poured into 
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the bowl first; then the granular portion is poured in.   The mixture is stirred vigorously 
for 2 minutes.  After the mixing stage it remains in a fluid, injectable state for the first 3 
minutes and, if allowed to set, it becomes moldable during the subsequent 3-5 minute 
interval.  The mixture reaches complete set after approximately 10-15 minutes.  
OsteoCrete exhibits a slight amount of expansion upon setting, which may be beneficial 
for retention.  OsteoCrete has been shown to resorb approximately 50% after 24 weeks 
in rabbits.12 
 An in vivo study comparing different bone cements showed positive results for 
the use of OsteoCrete. 11   They evaluated the bone-screw interfaces of screws inserted 
into the third metacarpal and metatarsal bones of horses. The study compared stainless 
steel (SS) bone screws (these were the controls), SS bone screws with Ca-cement, SS 
bone screws with Mg-cement (OsteoCrete), and SS bone screws with 
polymethylmethacrylate (PMMA).  The peak removal torque values for each group were 
1,701 +/- 164 Nmm, 1,665 +/- 148 Nmm, 2,383 +/- 198 Nmm, and 1,981 +/- 240 Nmm, 
respectively.  These differences were statistically significant, demonstrating a 40% 
increase in peak torque to failure in the OsteoCrete group compared to the controls.  This 
study measured the peak torque to failure rather than the pullout strength.  They stated 
that the pullout test evaluates the biomechanical holding power of the screw and the 
material surrounding it.  The peak removal torque value more closely reflects the 
strength and bonding characteristics of the screw interface as well as the resistance of the 
screw to back out from cyclic forces.  This is the most common mechanism of failure 
observed in situations clinically.  
17 
 
 In 2013, Sehlke et al performed a study to determine whether OsteoCrete can be 
used to stabilize dental implants in large extraction sockets and whether it is replaced by 
native bone.13  They extracted the mandibular third premolars and first molars of four 
mongrel dogs and placed immediate dental implants; the control sites received dental 
implants only and the experimental sites received OsteoCrete and dental implants.  All 
four dogs were euthanized four months after implant placement.  They performed 
histology and electron microscopy to analyze the BIC and the OsteoCrete surface texture 
and porosity.  Two of the experimental implants failed and the BIC of one of the control 
implants could not be calculated due to complete soft tissue integration.  They performed 
transmucosal single stage implant and abutment placement on the first dog.  However, 
after initial healing it was observed that the OsteoCrete had high levels of bacteria and 
plaque on the surface when exposed to the oral cavity.  This caused the OsteoCrete to 
discolor, soften, and dissolve.  They modified the study protocol and attempted primary 
closure in dogs 2, 3, and 4.   
All previous studies of OsteoCrete were performed under a closed, sterile 
surgical environment.11-13,51  Upon histologic evaluation, the residual OsteoCrete was 
inert and did not result in an inflammatory response.  There was new bone growth on the 
top of the OsteoCrete in experimental sites that achieved primary closure.  The 
histologic BIC was 51.7% ± 13.7% for experimental implants and 43.7% ± 8.1% for 
control implants.  The difference in BIC was not statistically significant.  Using SEM, 
they found that the external surface of the OsteoCrete had no external porosities, 
however it did show microstructural craze lines or cracks which is likely to have 
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occurred during setting of the material.  The authors recommend further investigation of 
OsteoCrete for dental applications. 
 No studies have been performed evaluating the effects of OsteoCrete on MSIs 
inserted into alveolar bone or OsteoCrete being used with SLA surface treated MSIs. 
 
SLA Surface Treatment 
Sand blasted large grit acid etched (SLA) implants undergo a subtractive process 
to increase their surface area.  Numerous studies have shown that SLA implants are 
superior to machined implants, based on removal torque, RFA, histomorphometric, and 
micro-CT analyses.9,26,32,53-57  SLA surfaces have been shown to have greater 
microtopography (increased surface area), which increases fibrinogen absorption.58  This 
could explain the observed increase in platelet adhesion. 
Buser et al performed a study in 1999 looking at differences in removal torque 
with machined, SLA, and TPS (titanium plasma sprayed) dental implants in the maxilla 
of miniature pigs.54  The machined surface implants had mean removal torque values 
(RTV) ranging from 0.13 to 0.26 Nm, and the RTV of the SLA and TPS groups ranged 
from 1.14 and 1.56 Nm.  4 weeks after healing, the SLA implants had higher mean RTV 
compared to the TPS implants (1.39 vs. 1.14 Nm), but these differences were not 
statistically significant.  They concluded that the removal torque or interface shear 
strength of titanium implants was significantly influenced by their surface 
characteristics.  This conclusion was based on the fact that the machined titanium 
surface demonstrated significantly lower RTV when compared with the TPS and SLA 
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surfaces.  Buser et al also performed a histomorphometric study investigating the 
difference in osseointegration of machined and SLA dental implants.55  They found that 
machined surfaces had 20-25% bone-to-implant contact and SLA surfaces had 50-60% 
bone-to-implant contact when observed on undecalcified transverse histologic sections.   
Klokkevold et al performed a study in 1997 using acid etched and machined 
implants in the femurs of ten New Zealand White rabbits.53  They found the removal 
torque value was 4 x higher for the acid etched surface implants when compared to the 
machined surface implants. The mean removal torque values were 20.50 +/- 6.59 Ncm 
and 4.95 +/- 1.61 Ncm for the acid etched and machined surfaces respectively. 
 
Pilot Holes 
A recent study using the Osstell Mentor to evaluate stability and the bone 
surrounding the MSIs found that pilot holes increase the initial stability, but they 
significantly decrease the stability over time.  It was thought that the pilot hole caused 
damage to the surrounding bone due to the drilling process and most likely overheating 
of the bone.33  This is the reason the present study used “down-sized” MSIs with a hand-
driver to place the pilot holes.  This should reduce the confounding variable of thermal 
bone damage which can be caused by the use of a pilot hole drill.  There is not a way to 
deliver the OsteoCrete into the bone prior to MSI placement without placing a pilot hole. 
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CHAPTER II 
EVALUATION OF MINI-SCREW IMPLANT STABILITY WITH OSTEOCRETE 
BONE CEMENT 
INTRODUCTION 
Many orthodontic treatments require skeletal anchorage in order to achieve the 
best results possible.  The most commonly used skeletal anchors in orthodontics are 
mini-screw implants (MSIs).  MSIs are important in orthodontic treatment of 
malocclusions requiring absolute anchorage such as bimaxillary protrusion treatments to 
obtain maximum retraction, intrusion protocols for open bite treatment, maxillary 
dentoalveolar distalization in Class II patients, and other orthodontic treatments to 
prevent unwanted reciprocal forces.  MSIs can be placed by the orthodontist; many 
times, at no additional cost to the patient.  Many orthodontists do not consider using 
MSIs when treating patients due to past experiences with MSI mobility and failures.  
When MSIs fail it can cause orthodontists to lose confidence in the use of MSIs and it 
can cause patients to lose confidence in the orthodontist.1  This can lead orthodontists to 
provide suboptimal treatment without skeletal anchorage.  A meta-analysis and two 
systematic reviews have reported MSI success rates to be 80%-86.5% in humans.2-4  The 
success rates of MSIs are significantly lower than the success rates of titanium 
endosseous dental implants, which have been reported to be 90% to 100%.5,6  The field 
of orthodontics needs a more predictable method for MSI placement, that increases the 
stability and success of MSIs.   
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MSIs typically exhibit significant decreases in stability during the first 3 weeks, 
up to the primary to secondary stability transition.7   Primary stability, which is 
mechanical and due to the cortical and trabecular bone contact with the MSI, decreases 
due to the osteoclastic removal of bone damaged due to the compression and 
microfractures during MSI placement. 8-10  Increases in secondary stability are due to 
cortical and trabecular bone repair and intimate contact with the MSI (osseointegration 
or bone-to-implant contact).  If the primary stability could be enhanced, it would 
minimize the initial decrease in stability and increase overall stability, leading to more 
successful MSIs. 
Primary stability could be enhanced if there were a bone cement that diffuses into 
the trabecular bone and bonds to the MSI.  Assuming that the cement resorbs over time, 
this would enhance the initial mechanical stability until full secondary stability could be 
achieved.  OsteoCrete is a magnesium based bone cement that has been shown to 
increase the stability of stainless steel screws in a horse study.11  OsteoCrete has been 
shown to be both biocompatible and osseoconductive.12,13  A dog study using immediate 
dental implants showed that there was new bone formation over the top of the 
OsteoCrete and minimal inflammatory reaction.13  There have not been any studies that 
have investigated at MSI placement with adjunctive bone cements.   
 The purpose of the present study was to evaluate the stability of MSIs placed 
with and without OsteoCrete bone cement.  Another purpose was to evaluate the tissue 
response to the OsteoCrete.   
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The hypothesis of the present study was that there would be a significantly higher 
stability for SLA MSIs placed with OsteoCrete compared to SLA MSIs only. 
 
MATERIALS AND METHODS 
Six periodontally healthy, beagle dogs 1 to 2 years of age, weighing between 
twenty and twenty-five pounds, served as the experimental models.  The dogs were 
purchased from Marshall Bioresources (DBA Marshall Farm Group, North Rose, NY).  
The project was approved by the Institutional Animal Care and Use Committee at Texas 
A&M University College of Dentistry (IACUC #2015-0294-CD).   
The animals were quarantined for 10 days.  On the day of OsteoCrete (Bone 
Solutions Inc, Colleyville, TX, USA) and mini-screw implant (MSI) placement, they 
were placed under general anesthesia using IM sedation, consisting of a combination of 
ketamine (2.2 mg/kg) and xylazine (0.22 mg/kg) and intubation, followed by 1% to 2.0% 
isoﬂurane in oxygen at 0.5 to 1 L per minute.  Vital signs were monitored throughout 
each procedure.  All dogs received a prophylaxis using an ultrasonic cavitron (Denstply, 
York, PA), irrigated with a 0.12% chlorhexidine gluconate solution.  A Planmeca Intra-
Oral X-Ray unit (Planmeca USA, Roselle, IL) was used to take periapical radiographs of 
the left and right maxillary quadrants using size 4 phosphorous films.  The radiographs 
were used to determine ideal MSI placement with adequate inter-radicular space.  Local 
anesthetic, consisting of 2% lidocaine with 1:100,000 epinephrine (Patterson Dental, St. 
Paul, MN), was administered via local infiltration of the maxillary vestibule with a 27 
gauge needle.   
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The MSIs used were made of medical grade titanium alloy.  They were sand 
blasted large grit acid etched (SLA) surface treated.  They were 7 mm long, with a 1.6 
mm outer diameter, a 1.1 mm internal diameter, and a 0.7-mm pitch (Neodent, Curitiba, 
Parana, Brazil) (Figure 1).  The head of the screw had a 1 mm high collar and a 1.1 mm 
internal thread fabricated to accept the Osstell IDx Smartpeg type A3 (Integration 
Diagnostics, Goteborg, Sweden).  The Smartpeg was used to measure the weekly 
implant stability quotient (Figure 1).  The Osstell IDx was calibrated prior to 
measurements.  The Osstell data was represented as the implant stability quotient (ISQ), 
which ranges from 1 to 100.  A larger ISQ indicates increased stiffness or stability.   
The experimental and control sides of each dog was randomly allocated using an 
Excel random number generator.  The protocol on the experimental side was to first drill 
all of the pilot holes in one maxillary quadrant.  Immediately after drilling, one package 
of OsteoCrete was hand mixed for 90 seconds (Figure 2A).  The OsteoCrete was then 
loaded into a 3 cc syringe with a thin-walled 18 gauge BD needle.  The needle was 
sectioned prior to surgery with a dental handpiece and metal cutting bur so that it was 
blunt and only 7 mm long.  The needle was inserted approximately 3 to 4 mm into each 
pilot hole.  Approximately 0.1 mL of OsteoCrete was injected into each of the four pilot 
holes using positive thumb pressure for approximately 2 seconds.  The syringe was 
backed out as the OsteoCrete was dispensed into the pilot hole (Figure 2B).  The lumen 
of the needle was kept patent with an 0.016” round stainless steel orthodontic wire.  The 
same MSIs used to drill the pilot holes were then placed into the four OsteoCrete filled 
pilot holes using a hand driver.  Each was inserted until the collar of the MSI was at the 
24 
 
level of the gingiva (Figure 2C).  A 2x2 gauze was used to wipe away any OsteoCrete 
and blood that extruded from the site.   
The protocol for the control sites in the other quadrant was to hand drill all of the 
pilot holes using the same 7 mm long SLA surface treated MSIs.  They were inserted 
until the MSI collar was at the level of the gingiva, then removed and replaced to 
replicate the protocol on the experimental side, albeit without OsteoCrete.  Periapical 
radiographs were taken to ensure proper MSI positioning and to verify that the MSIs had 
not contacted the roots (Figure 3).   
All of the MSIs were placed approximately 2 mm apical to the mucogingival 
junction in nonkeratinized gingiva.  There were four MSIs placed in each buccal 
quadrant of the maxilla; one dog had only three MSIs placed in each quadrant due to 
insufficient space.  MSI’s were placed between the canine and first premolar, and in the 
inter-radicular spaces of the 2nd, 3rd, and 4th premolars (Figure 4A).  All MSIs were 
placed parallel to the occlusal plane and perpendicular to the cortical plate.  There was a 
total of 46 MSIs placed in the six beagle dogs.  Analgesics (Nalbuphene, 1-2mg/kg 
subcutaneous BID for 3 days then PRN) and antibiotics (Penicillin G procaine with 
Benzathine, 20,000-40,000 units/kg at surgery) were administered in all cases. 
Immediately after placement, the MSIs were stabilized with a hemostat and the 
Smartpeg type A3 was screwed onto the MSI head and tightened using a thumb and 
index finger (Figure 4A and 4B).  The Osstell IDx transducer was oriented perpendicular 
to the long axis of the MSI and three separate measurements were recorded for each MSI 
(Figure 4C).  The three measurements were averaged.  The Smartpeg was removed by 
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reversing the insertion method.  Weekly measurements were taken, resulting in 10 
implant stability quotient measurements for each MSI over the nine week experimental 
period. 
 The dogs were sedated with 1.1 mL per kilogram of ketamine and 0.1 mg per 
kilogram of xylazine for the weekly measurements.  There was gingival overgrowth 
around most of the MSIs which inhibited the Smartpeg from being screwed into the head 
of the MSIs (Figure 4D).  The overgrowth was removed using a Vetroson V-10 Bi-Polar 
Electrosurgical Unit (Summit Hill Laboratories, Navesink, NJ) with the round loop tip.  
Calcein, alizarin, and calcein were administered at 4 weeks, 6 weeks, and 8 weeks 
respectively.  Calcein (7 mL for 14 kg dog, 10mg/kg) and Alizarin (28 mL for 14 kg 
dog, 20 mg/kg) were administered intravenously. 
 After the final measurements were taken at nine weeks, the animals were 
euthanized with 2 mL of Beuthanasia-D given intravenously and perfused with 1 to 2 L 
of normal saline solution, followed by 1 L of 4% paraformaldehyde (PFA). The maxillae 
were resected en bloc with a Stryker bone saw and stored in 4% PFA and refrigerated for 
approximately 3 to 4 weeks.  Each of the MSIs and the surrounding bone were trephined 
parallel to the long axis of the MSIs using a dremel with a 10 mm circular trephine bit 
(Figure 5A).  The maxillae were secured on a survey table that was attached to the 
platform stand of the dremel to ensure accurate long axis trephining.  The dremel was 
used at approximately 70% max speed, with water irrigation.  The specimens were then 
stored individually in labelled vials with 4% PFA and refrigerated. 
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Post Mortem Evaluations 
Histological Evaluation 
Twenty-one specimens were used for fluorescent histology (10 experimental and 
11 control) and six specimens were used for H&E histology (3 experimental and 3 
control).  The specimens were randomly selected. 
Confocal fluorescence was used to study the amount and location of OsteoCrete 
dispersion and new bone mineralization.  The fluorescent specimens were dehydrated in 
graded ethanol for two weeks and soaked in acetone for two days, methyl methacrylate 
monomer #1 for three days, and methyl methacrylate monomer #2 for four days.  They 
were embedded in methyl methacrylate until polymerization was complete.  The samples 
were sectioned at a low speed, perpendicular to the long axis of the MSIs with a Buehler 
Isomet Saw (Buehler, Houston, TX) using a diamond wafering blade.  The sections, 
which were approximately 150 μm thick, were ground and polished to approximately 
100 μm.  Three sections were selected from each specimen to evaluate the cortical, 
medullary, and apical levels of the MSI and bone.  The ﬂuorescent signal was imaged 
using a Photometrics CoolSnap K4 CCD camera (Roper Scientiﬁc, Duluth, Ga) mounted 
on a ﬂuorescent microscope (Nikon, Melville, NY) and NIS-Elements software (Nikon) 
at 5x magnification.  The fluorescent images for calcein (green) were captured using an 
excitation of 488 nm and an emission filter between 480 and 600 nm; the fluorescent 
images for alizarin (red) were captured using an excitation of 561 nm and an emission 
ﬁlter between 530 and 680 nm.   
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The fluorescent slides were then stained with Stevenel’s Blue and Van Gieson 
and imaged using a Kodak SPOT digital camera mounted on a Zeiss Axioplan 
microscope (Carl Zeiss Microimaging, Germany) and SPOT 5.0 Software (SPOT 
Imaging Solutions, Sterling Heights, MI) at 2.5x magnification.  Each slide was imaged 
on automatic contrast and then on higher intensity light in order to visualize the MSI and 
OsteoCrete separately. 
The H&E histology allowed visualization of inflammatory, osteoblast, and 
osteoclast activity.  The six specimens were decalcified in ethylenediaminetetraacetic 
acid (EDTA) for approximately three months (the MSIs were removed after 1 month of 
decalcification), dehydrated in graded ethanol, cleared with xylene, and embedded in 
paraffin. The blocks were then sectioned with a microtome in a perpendicular direction 
to what was the long axis of the MSI at a thickness of 6 μm.  The sections were mounted 
on glass slides, deparaffinized, rehydrated, and stained with hematoxylin and eosin.  
These samples were also imaged using a Kodak SPOT digital camera mounted on a 
Zeiss Axioplan microscope (Carl Zeiss Microimaging, Germany) and SPOT 5.0 
Software (SPOT Imaging Solutions, Sterling Heights, MI).   
MicroCT Evaluations 
 Fifteen MSIs from each of the experimental and control groups were randomly 
selected for µCT analysis (Bruker’s Skyscan 1173).  Two specimens, along with 4% 
PFA, were placed one on top of the other in a 14 mm diameter micro CT holder.  The 
specimens were scanned using a high isotropic resolution of 10 µm.  X-ray energy levels 
were set to 130 kVp, current was set to 61 uA, and integration time was 1000ms.  A 
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0.25mm Brass ﬁlter and a high resolution setting of 958 projections per 180º were used.  
The volume of interest of each specimen was deﬁned as a cylinder (6000um diameter) 
with the implant positioned in the center (Figure 6).  The average scanning time was 48 
minutes per specimen.  Based on ten randomly chosen specimens, grayscales of 45-255 
were used as thresholds to represent bone and the MSIs.  The grayscales of 110-255 
were used to represent only bone, removing the titanium screws so that they were not 
included in the analysis.  Datasets were reconstructed with Skyscan Nrecon software 
(Bruker, Kontich, Belgium). Reconstruction settings included a Gaussian smoothing of 
2, Ring Artifact Correction of 5, Beam Hardening Correction of 20%, and Dynamic 
Range of [-0.003-0.05]. 
The region of interest (ROI) was defined as 250 µm apical to the buccal cortical 
bone and extending 3 mm apically from that.  This was determined using the 
reconstructed 3-dimensional images and evaluating the length of the MSI within the 
alveolar bone prior to reaching the sinus.  All MSIs were within at least 3 mm of bone 
along their long axis from buccal cortical bone to maxillary sinus cortical bone.  The 
calculated ROI included a 10 µm layer of bone that extended 10 to 20 µm from the MSI 
surface (Figure 7). The voxel of bone adjacent to the MSI surface (0-10 µm) was 
excluded because it was subject to metallic halation artifacts.  Bone volume fractions 
(bone volume/total volume) and bone mineral density (g/cm3) were calculated for each 
ROI.  3-D renderings were made using the Nrecon software (Bruker, Kontich, Belgium) 
to show the density and trabeculation of the bone around the MSIs. 
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Statistical Analysis 
 Statistical Package for the Social Sciences (SPSS) 22.0 Software (SPSS Inc.; 
Chicago, IL) was used for the statistical analyses.   The Osstell IDx Implant Stability 
Quotients (ISQs) were normally distributed.  Means and standard deviations were used 
to describe the data and analyzed using paired samples t-tests.  The success and failure 
rates were analyzed using a chi-square test.  Bone volume fraction (TV/BV) and bone 
mineral density, which were not normally distributed, were described using medians and 
interquartile ranges.  They were analyzed using Wilcoxon Signed Ranks Tests.   
 
RESULTS 
Success Rates 
 There were three MSIs that failed on the control side and five that failed on the 
experimental OsteoCrete side (Table 1).  The MSIs were considered unsuccessful if they 
fell out between measurements or if they were mobile enough to where they were 
removed during placement and removal of the Smartpeg.  Only 2 of the MSIs fell out 
between measurements.  The remainder of the unsuccessful MSIs were mobile enough 
that they pulled out during careful placement and removal of the Smartpeg.  This 
resulted in a success rate of 87% (20 of 23 MSIs) for the control group and 78.3% (18 of 
23 MSIs) for the experimental group (Figure 8).  This difference was not statistically 
significant, with a chi-square of 0.6053 and a p-value of 0.437 (Table 2).  The tissues 
were inflamed around all MSIs within one to two weeks, and remained inflamed 
throughout the nine week experimental period.  This required the use of electrosurgery 
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to remove excessive gingival tissue over the MSIs when placing the Smartpeg for ISQ 
measurements. 
 
Osstell IDx ISQ 
 The ISQ values showed an initial decrease in stability during the first two weeks 
for both the experimental and control MSIs (Table 3, Figure 9).  Compared to the 
experimental MSIs, the control MSIs decreased slightly more from week 0 to week 1, 
and decreased slightly less from week 1 to week 2.  None of the group differences during 
the first two weeks were statistically significant.  The stability of the control MSIs 
increased markedly between weeks 2 and 5 and more slowly from week 5 to week 9.  
The experimental MSIs showed only slight increases of stability between weeks 2 and 9.  
Stability of the control MSIs was significantly higher than the stability of the 
experimental MSIs at week 4 (p=0.023) and at week 5 (p=0.010).  There also were 
differences at weeks 6 to 9 that closely approached statistically significant levels (week 
6: p=0.059, week 7: p=0.070, week 8: p=0.055, week 9: p=0.187). 
 
Confocal Fluorescence 
 On the fluorescent histological sections the OsteoCrete exhibited a black 
granulated appearance (Figure 10).  OsteoCrete was present in most of the mid 
trabecular and apical trabecular sections.  OsteoCrete was generally not present in the 
cortical sections.  There was no bone or indication of bone mineralization around the 
SLA MSIs where OsteoCrete was present.  There was bone mineralization around the 
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SLA MSIs where there was no OsteoCrete present.  There was no mineralization within 
the area covered by OsteoCrete, but there was mineralization along the interface between 
OsteoCrete and bone.  The control sections showed intimate bone contact and 
mineralization around the SLA MSIs.  The control sections consistently showed higher 
bone-to-implant contact than the experimental sections. 
 
Stevenel’s Blue 
The Stevenel’s Blue stained sections showed OsteoCrete around the MSIs as a 
dark grey area with a granulated appearance (Figure 11).  Osteoblasts were observed 
lining the trabecular bone on the side opposite from the OsteoCrete filled spaces.  There 
were no layers of osteoblasts observed on the side of the bone touching the OsteoCrete 
(Figure 11 and 12).  The bone surface next to the OsteoCrete appeared jagged and 
shredded.  In the control sections, there were layers of osteoblasts observed near the 
bone around the MSIs and along the trabecular spaces.  There were very few osteoclasts 
observed in the control sections and the OsteoCrete sections.  There were no osteoclasts 
observed against the OsteoCrete.  There were osteocytes observed in their lacunae 
throughout the cortical and trabecular bone of both experimental and control sections. 
 
Hematoxylin and Eosin 
 One of the experimental sections stained with H&E showed a fairly large area of 
OsteoCrete that ballooned out on one side of the MSI hole (Figure 13).  All of the 
sections showed areas of OsteoCrete that had a granular appearance, with bone directly 
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next to it, osteocytes within their lacunae, osteoblasts lining the bone facing away from 
the OsteoCrete, and no osteoclasts near or around the OsteoCrete.  The control sections 
showed normal bone with osteocytes, osteoblasts along the trabecular bone, and very 
few osteoclasts.  The control sections had trabecular bone around the MSI hole, showing 
where the MSI had been prior to removal for demineralization.  The OsteoCrete sections 
also showed a circular pattern, but there was less osteoid and bone matrix around the 
MSI hole. 
 
Micro Computed Tomography 
 The 3D renderings of the micro CT scans showed that the most apical portions of 
the MSIs were within the maxillary sinus (Figure 6).  The median for bone volume 
fraction (Bone Volume / Total Volume) was 46.45 for the control group and 48.36 for 
the experimental group (Figure 14).   The median for bone mineral density was 0.70 
g/cm3 for the control group and 0.72 g/cm3 for the experimental group (Figure 14).    
 
DISCUSSION 
MSIs placed into bone along with OsteoCrete are slightly less successful than 
MSIs placed in bone without OsteoCrete.  The success rate of the control MSIs (87%) 
was within the range of success rates found in the literature, while the success rate of the 
experimental MSIs (78.3%) was lower than previously reported studies.  The chi-square 
test showed that the failure rates were not significantly different.  Another dog study 
performed by Sehlke et al, found 100% implant survival for immediate placed control 
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implants and 75% survival for experimental immediate placed implants with 
OsteoCrete.13  Various other dog studies have reported similar or slightly higher MSI 
success rates.33,34,59  All of the MSIs in the present study were placed within 2 mm of the 
mucogingival junction in nonkeratinized gingiva.  This was necessary due to the limited 
inter-radicular space available for MSI placement and the short keratinized gingival 
areas in the beagle dogs.  Placement in the non-keratinized tissue could explain why the 
success rates were somewhat lower.  The absence of keratinized mucosa around MSIs 
significantly increases the risk of infection and failure.60  Human studies have reported 
slightly lower success rates (80-86.5%) than dog studies, due to their inability to control 
confounding factors such as diet, hygiene, trauma, etc.2-4   
MSIs are most susceptible to failure during the first four weeks after insertion.  
All of the MSI failures occurred between week 1 and week 4.  Ure et al found that there 
was a significantly greater decreases in stability during the initial 3 weeks after 
placement for MSIs that failed when compared to MSIs that remained stable.7  This is 
when MSIs and dental implants transition from primary stability to secondary stability, 
when overall stability dips to its lowest level.7,8,34,61  Berglundh et al found osteoclasts 
around implants as early as 4 days, new bone as early as 2 weeks, and lamellar bone by 4 
weeks.9  This supports the overall stability curve being least stable around 2 weeks and 
increasing in stability as bone formation continues and matures. 
The control MSIs showed the expected initial loss of primary stability followed 
by increased secondary stability.  Previous studies have shown similar stability 
curves.7,32-34  The ISQ data showed a decrease in stability for the control and 
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experimental groups during the first 2 weeks.  The primary stability, which has also been 
termed mechanical stability, is due primarily to the cortical bone.8,30  The initial decline 
in primary stability is due to the remodeling of the cortical bone, with osteoclasts being 
present as early as 4 days post-implant placement.8,9  The secondary stability occurs as a 
result of bone remodeling and healing, with more new bone formation than bone 
resorption within the cortical and trabecular bone.8,9,30  This was observed in the 
fluorescent histology sections with the green, red, green fluorescent labels showing 
active bone remodeling directly next to the MSI and throughout the adjacent cortical and 
trabecular bone in control MSIs. 
MSIs inserted with OsteoCrete also undergo the initial decrease in primary 
stability, but they do not show the expected increases in secondary stability.  The 
primary stability decrease occurred similarly in both the control and experimental 
groups, probably because little or no OsteoCrete was present in the cortical layer.  There 
was a more rapid and greater increase of secondary stability for the control group than 
the experimental group.  This difference could have been due to more limited ability for 
trabecular bone healing around the MSIs in the experimental group.  OsteoCrete likely 
acted as a barrier for new bone formation.  Without new bone around the MSIs, micro-
motion, expansion, or cracks and craze lines could result in less stable MSIs.  Sehlke et 
al found that the external surface of the OsteoCrete placed with dental implants had no 
external porosities.  However it did show microstructural craze lines or cracks, which 
likely occurred during setting of the material.13  In the present study, craze lines could 
have also occurred during the placement and removal of the Smartpeg during weekly 
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stability measurements.  Native bone has the ability to self-repair, whereas OsteoCrete 
does not.  In contrast to the present results, Hirvinen et al found that stainless steel 
screws placed with OsteoCrete in horse metacarpal bones had 40% greater removal 
torque than stainless steel screws placed without OsteoCrete.11  It is possible that the 
OsteoCrete cement has different bonding characteristics with stainless steel than with the 
titanium MSIs used in our study.  The OsteoCrete flaked or crumbled off of the titanium 
MSIs during pilot testing.  Cadaveric orthopedic studies have shown that vertebral 
screws placed with polymethylmethacrylate or calcium phosphate cements also have an 
increased pullout strength.62  The polymethylmethacrylate had the highest pullout 
strength, but it is non-resorbable and would not allow normal healing after the removal 
of the MSI.  Moreover, cadaveric pullout strength does not closely relate to in vivo 
stability, which limits the clinical applicability of their results.62 
Bone mineralization and remodeling occur directly next to and around MSIs 
placed without OsteoCrete. The fluorescent histological images and Stevenel’s blue 
histological images showed bone mineralization occurring directly next to the MSI and 
throughout the cortical and trabecular bone of the control sections.  Numerous other dog 
studies have reported similar bone mineralization around MSIs.33,34   
Bone mineralization occurs around the outer boundaries of OsteoCrete but not 
within the OsteoCrete.  Comparison of the same fluorescent and Stevenel’s blue 
histological sections made it possible to differentiate the areas of bone that underwent 
active bone mineralization.  This showed that there was not any bone mineralization 
occurring within the OsteoCrete.  Increased pressure from the injection of the 
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OsteoCrete could have resulted in the loss of blood supply to these areas, with resultant 
necrosis of the osteoblasts.  Alternatively, it may just act as a physical barrier that 
inhibits the osteoblasts from laying down new bone.  The histological sections showed 
bone in direct contact with OsteoCrete but there were no osteoblasts, suggesting that 
OsteoCrete limited new bone formation.  The opposite side of the bone (i.e. the side 
away from the OsteoCrete) appeared normal with a layer of osteoblasts.  There was bone 
mineralization occurring in the areas directly around the OsteoCrete.  Selkhe et al 
reported that the OsteoCrete appeared to be inert and did not result in an increased 
inflammatory response.13  They also showed that there was new bone growth over the 
OsteoCrete in the experimental sites that achieved primary closure.  This supports the 
claim made by OsteoCrete that it is osseoconductive, meaning that it allows bone 
formation.11  However, it does not induce bone formation or resorption.  In a rabbit study 
that created cranial defects and monitored bony infill, a narrower gap width and greater 
bone inﬁll density occurred for the unﬁlled control sites than the OsteoCrete filled 
cranial defects.12  Bone infill progresses quicker when cement does not have to be 
reabsorbed prior to bone remodeling.  This further supports the notion that the 
OsteoCrete may act as a physical barrier to normal bone formation around the MSI, until 
it can be either absorbed or resorbed.  A rabbit study showed that 50% of the OsteoCrete 
remained at 24 weeks.12  Sehlke et al found that their histological specimens showed no 
adverse biologic response to OsteoCrete, but only minimal replacement at 4 months.13  
The time it takes OsteoCrete to resorb may limit its use in orthodontics. 
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The OsteoCrete is not being actively remodeled by osteoclasts.  The present 
histological results showed similar numbers of osteoclasts on the experimental and 
control sections.  They also did not show more inflammatory cells around the 
OsteoCrete, indicating that it is biocompatible.  Sehlke et al reported that, upon 
histologic evaluation, the OsteoCrete appeared to be inert and did not result in an 
increased inflammatory response.13  OsteoCrete does not contain any of the hormones or 
proteins that are needed for hematopoietic cells to recognize and initiate osteoclast 
differentiation and active resorption, such as PTH (parathyroid hormone), RANKL 
(Receptor Activator of Nuclear factor-Kappa Ligand), osteopontin (OPN), CSF-1 
(Colony Stimulating Factor-1), or MCP-1 (monocyte chemoattractant protein-1).63,64  
RANKL is produced by osteoblasts naturally and in response to PTH.  Osteoclast 
precursors express the RANK receptor that binds RANKL and causes the fusion and 
differentiation of osteoclasts.  OsteoCrete also lacks the proteins that are necessary to 
stimulate bone formation by osteoblasts, such as osteopontin (OPN), sclerostin, and 
collagen type I.64   Without the necessary proteins and hormones to induce osteoclasts 
and osteoblasts, OsteoCrete mainly serves as a bone filler that is very slowly absorbed 
and replaced by bone. 
In the layer of bone around the experimental and control MSIs, there was no 
difference in bone volume fraction or bone mineral density.  The experimental group had 
a slightly higher bone volume fraction and bone mineral density than the control group, 
but the difference was not statistically significant.  This can be explained by the fact that 
OsteoCrete is denser than cortical and especially trabecular bone, due to the high mineral 
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content, and it solidifies as one large piece of cement with few spaces compared to 
trabecular bone.  In the present study, bone volume fraction and bone mineral density 
were not good measures of MSI stability due to the inability to differentiate between the 
OsteoCrete and bone. 
 
Clinical Implications 
The clinical implications of this study are that OsteoCrete does not make MSIs 
more stable.  It makes them less stable.  OsteoCrete could be used as a bone filler in a 
sterile orthopedic environment, where it can slowly be absorbed and replaced with bone.  
However, it is replaced much too slowly to be beneficial in MSI and dental implant 
applications.  MSIs and dental implants are generally loaded much sooner than the 
replacement of OsteoCrete allows, resulting in failures due to the lack of adequate 
osseointegration.  If proteins that induce osteoclast and osteoblast formation could be 
added to OsteoCrete, it may serve as a better adjunctive to be used with MSI and dental 
implant placement. 
  
Limitations 
There were some limitations of the present study that were not foreseen.  
Initially, it was difficult getting the OsteoCrete to predictably flow through the needle 
used for injection into the MSI pilot hole.  The OsteoCrete granules had to be ground 
finer and more saline had to be added.  The smallest needle that would allow the new 
formulation of OsteoCrete to flow through was a thin-walled 18 gauge BD needle.  The 
39 
 
outer diameter of this needle was approximately 1.1 mm, which was the sames size as 
the inner diameter of the MSI.  This resulted in having to push the needle through the 
hole in the mucosa, the hole in the cortical bone, and into the medullary space.  All of 
the MSIs were placed in slightly movable, non-keratinized mucosa, which also made it 
difficult to position the needle and find the hole in the cortical bone.  For these reasons, 
there were some experimental sites that did not receive very much OsteoCrete if any.  
Another limitation of this study was the generalized gingival inflammation around the 
MSIs that occurred.  This resulted in having to remove the gingival tissue in order to 
screw the SmartPeg into place for Osstell ISQ measurements.  Initially, a 12 blade 
scalpel was used first to remove the gingival tissue.  Due to difficulties encountered, an 
electrosurgery unit was used in most instances for gingival tissue removal.   
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CHAPTER III 
CONCLUSIONS 
From the present study, the following conclusions can be made: 
1. The MSIs were most susceptible to failure between weeks 1 and 4. 
2. Secondary stability is lower with the use of OsteoCrete and does not approach 
initial stability values after 9 weeks. 
3. There was not any bone formation within the OsteoCrete, however there was 
bone formation around the OsteoCrete. 
4. OsteoCrete is biocompatible, but does not actively remodel. 
5. µCT bone volume fraction and bone mineral density are not good measures of 
MSI stability due to the inability to differentiate between OsteoCrete and bone.  
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APPENDIX A 
Table 1.  Osstell Implant Stability Quotient (ISQ) Weekly Measurements.  Dog number, 
E/C: Experimental/Control, Side: Lt=Left or Rt=Right, Site: C=Canine or PM=Pre-
molar, X=MSIs that failed. 
Dog  E/C Side Site 
Wk 
0 
Wk 
1 
Wk 
2 
Wk 
3 
Wk 
4 
Wk 
5 
Wk 
6 
Wk 
7 
Wk 
8 
Wk 
9 
A E Lt PM2 39 28 25 25 25 28 28 28 28 28 
A C Rt PM2 32 32 30 32 32 35 35 35 30 22 
A E Lt PM2/PM3 30 22 22 20 22 20 20 20 20 20 
A C Rt PM2/PM3 28 25 25 28 25 28 30 30 30 28 
A E Lt PM3 22 20 20 20 20 17 17 20 20 20 
A C Rt PM3 22 22 20 22 22 22 22 22 22 22 
A E Lt PM4 25 17 22 25 25 22 25 22 25 25 
A C Rt PM4 25 25 25 28 28 30 30 30 28 30 
B E Rt PM2 44 42 35 39 25 22 20 20 22 22 
B C Lt PM2 35 32 28 28 28 28 25 28 25 28 
B E Rt PM3 10 28 X X X X X X X X 
B C Lt PM3 22 22 20 17 20 20 20 20 20 20 
B E Rt PM4 25 25 20 20 20 22 22 22 22 25 
B C Lt PM4 25 22 22 22 20 20 20 20 22 22 
C E Lt PM2 30 30 25 25 22 22 22 25 25 25 
C C Rt PM2 30 22 22 25 25 28 28 28 28 30 
C E Lt PM2/PM3 22 22 22 22 22 22 22 22 22 22 
C C Rt PM2/PM3 28 22 25 25 28 28 22 28 28 28 
C E Lt PM3 7 X X X X X X X X X 
C C Rt PM3/4 10 10 14 17 20 20 20 17 22 35 
C E Lt PM4 20 15.5 X X X X X X X X 
C C Rt PM4 22 22 25 22 25 25 22 22 25 25 
D E Rt C/PM1 35 30 22 22 22 22 22 25 22 22 
D C Lt C/PM1 28 17 7 X X X X X X X 
D E Rt PM2 20 25 22 22 22 22 22 22 22 20 
D C Lt PM2 28 25 22 22 22 25 25 25 25 25 
D E Rt PM3 14 10 7 7 7 7 3 0 3 3 
D C Lt PM3 14 10 X X X X X X X X 
D E Rt PM4 20 25 20 22 22 20 20 20 20 20 
D C Lt PM4 22 20 17 17 17 17 17 17 17 17 
E E Lt C/PM1 25 10 X X X X X X X X 
E C Rt C/PM1 28 20 20 17 22 20 22 22 22 25 
E E Lt PM2 22 20 20 20 22 22 22 22 22 22 
E C Rt PM2 22 20 22 22 25 25 25 25 25 25 
E E Lt PM3 20 14 10 10 10 10 10 10 10 10 
E C Rt PM3 17 14 7 7 X X X X X X 
E E Lt PM4 17 7 14 14 17 17 17 17 20 20 
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Table 1 Continued. 
Dog  E/C Side Site 
Wk 
0 
Wk 
1 
Wk 
2 
Wk 
3 
Wk 
4 
Wk 
5 
Wk 
6 
Wk 
7 
Wk 
8 
Wk 
9 
E C Rt PM4 20 14 20 17 17 17 17 17 20 20 
F E Rt C/PM1 32 25 14 X X X X X X X 
F C Lt C/PM1 30 20 14 14 17 20 20 20 18.5 17 
F E Rt PM2 25 25 25 25 25 28 28 28 28 28 
F C Lt PM2 30 28 28 30 28 28 30 28 30 30 
F E Rt PM3 14 14 7 7 10 14 20 20 20 20 
F C Lt PM3 14 10 10 14 14 14 14 14 17 14 
F E Rt PM4 20 17 20 22 22 22 22 25 25 22 
F C Lt PM4 17 14 17 20 20 20 21 22 22 22 
 
 
Table 2.  Chi-Square for Control and Experimental MSIs Success and Failures. 
 Success Failure  
MSIs 18 5 Chi-square statistic = 0.6053 
OsteoCrete + MSIs 20 3 P-value = 0.437 
 
 
Table 3.  Osstell IDx Implant Stability Quotient (ISQ) Statistics.  Average weekly ISQ values for 
the Control and OsteoCrete groups and paired samples T-test. 
 Control OsteoCrete Side Differences 
Week Mean SD Mean SD Mean P-value 
0 23.87 6.41 23.39 8.80 0.48 0.636 
1 20.35 6.27 21.43 8.10 -0.61 0.632 
2 20.00 6.44 19.57 6.78 -0.22 0.852 
3 21.24 6.16 20.39 7.48 1.31 0.299 
4 22.75 4.72 20.00 5.48 2.00 0.023 
5 23.50 5.30 19.94 5.35 3.00 0.010 
6 23.25 5.25 20.11 5.88 2.27 0.059 
7 23.50 5.45 20.44 6.55 2.40 0.070 
8 23.83 4.23 20.89 5.95 1.87 0.055 
9 24.25 5.26 20.78 5.95 1.60 0.187 
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APPENDIX B 
 
Figure 1.  MSI and Osstell IDx Components.  (a) Neodent 7mm SLA MSI (b) MSI Hand 
Driver (c) Osstell IDx (d) Transducer (e) SmartPeg Type A3 (f) SmartPeg Wrench 
 
 
 
Figure 2.  OsteoCrete Mixing and Placement with MSI.  (A) OsteoCrete Mixing.  (B) 
OsteoCrete Injection (C) MSI Placement Using Hand Driver 
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Figure 3.  Post-op MSI Placement Radiographs. 
 
 
 
Figure 4.  ISQ Measurements.  (A and B) SmartPeg Type A3 Placement.  (C) Osstell 
ISQ Measurements.  (D) Gingival Inflammation.   
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Figure 5.  Trephine and Microscopes.  (A) Trephoning of MSI Samples.  (B) Confocal 
Microscope.  (C) Light Microscope. 
 
 
 
Figure 6. µCT Analysis.  X,Y,Z orientations showing MSI within maxillary bone 
between tooth roots (a).  The apical portion of most MSIs were within the maxillary 
sinus (b).  The buccal cortical bone is the side towards the head of the MSIs.  The left 
three orientations are from the experimental group and OsteoCrete (c) can be seen in the 
lower right orientation.  The right three orientations are from the control group. 
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Figure 7. µCT 3D Renderings and ROI.  MSI (a) was segmented out and 3D ROI/VOI 
(b) was 10-20 µm around each MSI.  The two middle ROI’s are experimental and the 
outer two are controls, which little difference can be observed. 
 
 
 
Figure 8.  Control and Experimental Success and Failure Rates. 
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Figure 9.  Osstell Implant Stability Quotient Data.  Control vs. Experimental.   
 
 
 
Figure 10.  Confocal Fluorescent Histological Images.  The upper row of images is from 
the experimental group and shows OsteoCrete (*) spread and lack of bone mineralization 
within the OsteoCrete around the MSI.  The lower row of images is from the control 
group and shows bone-to-implant contact and normal bone mineralization around the 
MSI. Within each row, the left two images are cortical sections, middle two images are 
mid trabecular sections, and the right two images are apical trabecular sections as 
depicted by the MSI image on the left.  
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Figure 11. Stevenel’s Blue Histological Images.  The upper row of images is from the 
experimental group and shows OsteoCrete (*) spread and lack of bone mineralization 
within the OsteoCrete around the MSI.  The lower row of images is from the control 
group and shows bone-to-implant contact and normal bone mineralization around the 
MSI. Within each row, the left two images are cortical sections, middle two images are 
mid trabecular sections, and the right two images are apical trabecular sections as 
depicted by the MSI image.  
 
 
 
Figure 12.  Stevenel’s Blue Experimental Slide.  (A) 2.5X Magnification.  (B) 10X 
Magnification.  (C) 20X Magnification.  The (*) points out the osteoblast layer and the 
(+) points out the jagged bone along the side with OsteoCrete where bone was laid down 
up to the OsteoCrete.   
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Figure 13.  H&E Slides.  Experimental (A) 2.5X Magnification.  (B) 10X Magnification.  
(C) 20X Magnification.  Control (D) 2.5X Magnification.  (E) 10X Magnification.  (F) 
20X Magnification. The (*) points out where OsteoCrete was present and the (+) points 
out where osteoblasts were present. 
 
 
 
Figure 14. µCT Bone Volume Fraction and Bone Mineral Density.  Control vs. 
Experimental. 
